Company Pacific Biosciences of California, Inc. Deutsche Boerse AG
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.889 EUR | +11.12% | +41.52% | -78.54% |
Business Summary
Number of employees: 796
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Instrument
60.1
%
| 49 | 38.0 % | 120 | 60.1 % | +147.24% |
Consumable
31.6
%
| 60 | 46.7 % | 63 | 31.6 % | +5.74% |
Service and Other
8.3
%
| 20 | 15.3 % | 17 | 8.3 % | -15.08% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
52.6
%
| 70 | 54.2 % | 105 | 52.6 % | +51.54% |
Asia-Pacific
27.2
%
| 36 | 28.2 % | 54 | 27.2 % | +50.65% |
Europe, Middle East, and Africa
20.3
%
| 23 | 17.6 % | 41 | 20.3 % | +79.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 13/07/00 |
Christian Henry
CEO | Chief Executive Officer | 56 | 31/07/18 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 27/09/20 |
Mark van Oene
COO | Chief Operating Officer | 51 | 07/01/21 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/03 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 16/12/14 |
Todd Friedman
IRC | Investor Relations Contact | - | - |
Mike Goloubef
PRN | Corporate Officer/Principal | - | 31/12/19 |
Natalie Welch
HRO | Human Resources Officer | - | 30/09/08 |
Neil Ward
PRN | Corporate Officer/Principal | - | 07/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 17/07/13 |
Marshall Mohr
BRD | Director/Board Member | 67 | 17/01/12 |
Christian Henry
CEO | Chief Executive Officer | 56 | 31/07/18 |
Director/Board Member | 70 | 31/12/08 | |
Lucy Shapiro
BRD | Director/Board Member | 83 | 11/09/12 |
Bill Ericson
BRD | Director/Board Member | 65 | 31/12/03 |
Kathy Ordoñez
BRD | Director/Board Member | 73 | 16/12/14 |
David Meline
BRD | Director/Board Member | 66 | 12/10/23 |
Hannah Valantine
BRD | Director/Board Member | 72 | 15/06/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 272,343,392 | 267,249,718 ( 98.13 %) | 0 | 98.13 % |
Company contact information
Pacific Biosciences of California, Inc.
1305 O'Brien Drive
94025, Menlo Park
+650 521 8000
http://www.pacb.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.23% | 218B | |
+6.88% | 184B | |
+12.98% | 135B | |
-0.27% | 62.38B | |
+11.58% | 51.37B | |
+7.76% | 50.9B | |
+1.23% | 40.87B | |
+3.00% | 36.28B | |
+25.54% | 31.88B |
- Stock Market
- Equities
- PACB Stock
- P09 Stock
- Company Pacific Biosciences of California, Inc.